<p><a href="http://us.rd.yahoo.com/dailynews/rss/business/*http://news.yahoo.com/s/nm/20080409/bs_nm/pfizer_nektar_dc"><img src="http://d.yimg.com/us.yimg.com/p/nm/20080409/2008_04_09t085557_318x450_us_pfizer_nektar.jpg?x=9 1&y=130&q=85&sig=oM09paCDgIuCBfH.uNHR8g--" align="left" height="130" width="91" alt="A man stands inside the Belgian headquarters of U.S. pharmaceutical giant Pfizer, in Brussels January 23, 2007. (Francois Lenoir/Reuters)" border="0" /></a>Reuters - Pfizer Inc and Nektar
Therapeutics said on Wednesday clinical trials of the
inhaled insulin Exubera found increased cases of lung cancer,
leading Nektar to end talks with potential partners to market
the product.</p><br clear="all"/>
View the entire article:
Pfizer warns of lung cancer with inhaled insulin
(Reuters)
Pfizer warns of lung cancer with inhaled insulin
(Reuters)
Linear Mode
